3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Carcinoma, Renal Cell
64
Breast Neoplasms
20
Kidney Neoplasms
19
Gastrointestinal Stromal Tumors
16
Neoplasms
15
Carcinoma, Non-Small-Cell Lung
10
Neoplasm Metastasis
9
Prostatic Neoplasms
8
Urinary Bladder Neoplasms
7
Brain Neoplasms
7
Colorectal Neoplasms
6
Neuroendocrine Tumors
5
Carcinoma, Hepatocellular
5
Carcinoma
5
Thyroid Neoplasms
4
Stomach Neoplasms
4
Small Cell Lung Carcinoma
4
Ovarian Neoplasms
4
Liver Neoplasms
4
Thyroid Cancer, Papillary
3
Sarcoma
3
Pancreatic Neoplasms
3
Leukemia, Myelomonocytic, Chronic
3
Kidney Diseases
3
Glioblastoma
3
Esophageal Neoplasms
3
Clear-cell metastatic renal cell carcinoma
3
Astrocytoma
3
Adenoma, Islet Cell
3
Adenocarcinoma, Follicular
3
Interventions
selpercatinib
2
pralsetinib
2
pembrolizumab
2
Pemetrexed
2
Paclitaxel
2
Carboplatin
2
patritumab
1
osimertinib
1
napabucasin
1
efineptakin alfa
1
durvalumab
1
cobimetinib
1
atezolizumab
1
alectinib
1
Tyrosine Kinase Inhibitors
1
Radiosurgery
1
Proton Therapy
1
Metformin
1
Gemcitabine
1
Erlotinib Hydrochloride
1
Dasatinib
1
Cisplatin
1
Bevacizumab
1
Afatinib
1
130-nm albumin-bound paclitaxel
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Has results
×
Thoracic Neoplasms
×
Sunitinib
×
Clear all
No trials found.